Fasting is a common dietary intervention known for its protective effects against metabolic and cardiovascular diseases. While its effects are mostly systemic, understanding tissue-specific changes in the heart is crucial for the identification of the mechanisms underlying fasting-induced cardioprotection. In this study, we performed a proteomic analysis of the fasting heart and attempted to clarify the molecular basis of fasting-induced cardioprotection. Our investigation identified a total of 4,652 proteins, with 127 exhibiting downregulation and 118 showing upregulation after fasting. Annotation analysis highlighted significant changes in processes such as lipid metabolism, the peroxisome pathway, and reactive oxygen species metabolism. Notably, the HIF-1 signaling pathway emerged as one of the focal points, with various HIF-1 targets exhibiting differential responses to fasting. Further experiments demonstrated downregulation of HIF-1α at both transcript and protein levels. Intriguingly, while gene expression of Egln3 decreased, its protein product PHD3 remained unaffected by fasting. The unchanged levels of pro-inflammatory cytokines indicated that the observed reduction in Hif1a expression did not stem from a decrease in basal inflammation. These findings underscore the complex regulation of the well-established cardioprotective HIF-1 signaling within the heart during 3-day fasting.

Department of Physiology Faculty of Science Charles University Prague Czechia

Laboratory of Developmental Cardiology Institute of Physiology of the Czech Academy of Sciences Prague Czechia

Zobrazit více v PubMed

Aksungar F. B., Topkaya A. E., Akyildiz M. (2007). Interleukin-6, C-reactive protein and biochemical parameters during prolonged intermittent fasting. Ann. Nutr. Metab. 51 (1), 88–95. 10.1159/000100954 PubMed DOI

Alanova P., Alan L., Opletalova B., Bohuslavova R., Abaffy P., Matejkova K., et al. (2024). HIF-1α limits myocardial infarction by promoting mitophagy in mouse hearts adapted to chronic hypoxia. Acta Physiol. (Oxf) 240, e14202. 10.1111/apha.14202 PubMed DOI

Alanova P., Chytilova A., Neckar J., Hrdlicka J., Micova P., Holzerova K., et al. (2017). Myocardial ischemic tolerance in rats subjected to endurance exercise training during adaptation to chronic hypoxia. J. Appl. Physiol. 122 (6), 1452–1461. 10.1152/japplphysiol.00671.2016 PubMed DOI

An S., Shi J., Huang J., Li Z., Feng M., Cao G. (2023). HIF-1α-induced upregulation of m6A reader IGF2BP1 facilitates peripheral nerve injury recovery by enhancing SLC7A11 mRNA stabilization. Vitro Cell Dev. Biol. Anim. 59 (8), 596–605. 10.1007/s11626-023-00812-z PubMed DOI

Arumugam T. V., Alli-Shaik A., Liehn E. A., Selvaraji S., Poh L., Rajeev V., et al. (2023). Multiomics analyses reveal dynamic bioenergetic pathways and functional remodeling of the heart during intermittent fasting. Elife 12. 10.7554/eLife.89214 PubMed DOI PMC

Balkova P., Jezkova J., Hlavackova M., Neckar J., Stankova B., Kolar F., et al. (2009). Dietary polyunsaturated fatty acids and adaptation to chronic hypoxia alter acyl composition of serum and heart lipids. Br. J. Nutr. 102 (9), 1297–1307. 10.1017/S0007114509389242 PubMed DOI

Benak D., Holzerova K., Hrdlicka J., Kolar F., Olsen M., Hlavackova M., et al. (2024a). Epitranscriptomic regulation in fasting hearts: implications for cardiac health. RNA Biol. 21 (1), 1–14. 10.1080/15476286.2024.2307732 PubMed DOI PMC

Benak D., Kolar F., Hlavackova M. (2024b). Epitranscriptomic regulations in the heart. Physiol Res. 73 (Suppl 1), S185–S19. 10.33549/physiolres.935265 PubMed DOI PMC

Benak D., Kolar F., Zhang L., Devaux Y., Hlavackova M. (2023). RNA modification m(6)Am: the role in cardiac biology. Epigenetics 18 (1), 2218771. 10.1080/15592294.2023.2218771 PubMed DOI PMC

Benak D., Sotakova-Kasparova D., Neckar J., Kolar F., Hlavackova M. (2019). Selection of optimal reference genes for gene expression studies in chronically hypoxic rat heart. Mol. Cell Biochem. 461 (1-2), 15–22. 10.1007/s11010-019-03584-x PubMed DOI

Cai Z., Zhong H., Bosch-Marce M., Fox-Talbot K., Wang L., Wei C., et al. (2008). Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. Cardiovasc Res. 77 (3), 463–470. 10.1093/cvr/cvm035 PubMed DOI

Gorlach A. (2009). Regulation of HIF-1alpha at the transcriptional level. Curr. Pharm. Des. 15 (33), 3844–3852. 10.2174/138161209789649420 PubMed DOI

Halestrap A. P., Pereira G. C., Pasdois P. (2015). The role of hexokinase in cardioprotection - mechanism and potential for translation. Br. J. Pharmacol. 172 (8), 2085–2100. 10.1111/bph.12899 PubMed DOI PMC

Holzerova K., Hlavackova M., Zurmanova J., Borchert G., Neckar J., Kolar F., et al. (2015). Involvement of PKCepsilon in cardioprotection induced by adaptation to chronic continuous hypoxia. Physiol. Res. 64 (2), 191–201. 10.33549/physiolres.932860 PubMed DOI

Kegg pathway (2021). HIF-1 signaling pathway - Rattus norvegicus (rat). Available at: https://www.genome.jp/pathway/rno04066.

Kohler D., Staniak M., Tsai T. H., Huang T., Shulman N., Bernhardt O. M., et al. (2023). MSstats version 4.0: statistical analyses of quantitative mass spectrometry-based proteomic experiments with chromatography-based quantification at scale. J. Proteome Res. 22 (5), 1466–1482. 10.1021/acs.jproteome.2c00834 PubMed DOI PMC

Li Q., Ni Y., Zhang L., Jiang R., Xu J., Yang H., et al. (2021). HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Signal Transduct. Target Ther. 6 (1), 76. 10.1038/s41392-020-00453-8 PubMed DOI PMC

Liang L., Zhu Y., Li J., Zeng J., Wu L. (2022). ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription. J. Exp. Clin. Cancer Res. 41 (1), 261. 10.1186/s13046-022-02462-7 PubMed DOI PMC

Liepinsh E., Makrecka M., Kuka J., Makarova E., Vilskersts R., Cirule H., et al. (2014). The heart is better protected against myocardial infarction in the fed state compared to the fasted state. Metabolism 63 (1), 127–136. 10.1016/j.metabol.2013.09.014 PubMed DOI

Ma X., Dong Z., Liu J., Ma L., Sun X., Gao R., et al. (2022). β-Hydroxybutyrate exacerbates hypoxic injury by inhibiting HIF-1α-Dependent glycolysis in cardiomyocytes-adding fuel to the fire? Cardiovasc Drugs Ther. 36 (3), 383–397. 10.1007/s10557-021-07267-y PubMed DOI PMC

Moritz C. P. (2017). Tubulin or not tubulin: heading toward total protein staining as loading control in western blots. Proteomics 17 (20). 10.1002/pmic.201600189 PubMed DOI

Nan Y., Liu S., Luo Q., Wu X., Zhao P., Chang W., et al. (2023). m(6)A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1α activation. Cell Rep. 42 (10), 113273. 10.1016/j.celrep.2023.113273 PubMed DOI

Neckar J., Hsu A., Hye Khan M. A., Gross G. J., Nithipatikom K., Cyprova M., et al. (2018). Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3. Am. J. Physiol. Heart Circ. Physiol. 315 (5), H1148-H1158–h58. 10.1152/ajpheart.00726.2017 PubMed DOI PMC

Ostadal B., Ostadalova I., Szarszoi O., Netuka I., Olejnickova V., Hlavackova M. (2021). Sex-dependent effect of perinatal hypoxia on cardiac tolerance to oxygen deprivation in adults. Can. J. Physiol. Pharmacol. 99 (1), 1–8. 10.1139/cjpp-2020-0310 PubMed DOI

Palazon A., Goldrath A. W., Nizet V., Johnson R. S. (2014). HIF transcription factors, inflammation, and immunity. Immunity 41 (4), 518–528. 10.1016/j.immuni.2014.09.008 PubMed DOI PMC

Pokorna Z., Jirkovsky E., Hlavackova M., Jansova H., Jirkovska A., Lencova-Popelova O., et al. (2019). In vitro and in vivo investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline. Clin. Sci. (Lond). 133 (16), 1827–1844. 10.1042/CS20190139 PubMed DOI

Puchowicz M. A., Zechel J. L., Valerio J., Emancipator D. S., Xu K., Pundik S., et al. (2008). Neuroprotection in diet-induced ketotic rat brain after focal ischemia. J. Cereb. Blood Flow. Metab. 28 (12), 1907–1916. 10.1038/jcbfm.2008.79 PubMed DOI PMC

Semenovykh D., Benak D., Holzerova K., Cerna B., Telensky P., Vavrikova T., et al. (2022). Myocardial m6A regulators in postnatal development: effect of sex. Physiol. Res. 71 (6), 877–882. 10.33549/physiolres.934970 PubMed DOI PMC

Shmakova A., Frost M., Batie M., Kenneth N. S., Rocha S. (2021). PBRM1 cooperates with YTHDF2 to control HIF-1a protein translation. Cells 10 (6), 1425. 10.3390/cells10061425 PubMed DOI PMC

Snorek M., Hodyc D., Sedivý V., Durišová J., Skoumalová A., Wilhelm J., et al. (2012). Short-term fasting reduces the extent of myocardial infarction and incidence of reperfusion arrhythmias in rats. Physiol. Res. 61 (6), 567–574. 10.33549/physiolres.932338 PubMed DOI

Sonanez-Organis J. G., Vazquez-Medina J. P., Crocker D. E., Ortiz R. M. (2013). Prolonged fasting activates hypoxia inducible factors-1α, -2α and -3α in a tissue-specific manner in northern elephant seal pups. Gene 526 (2), 155–163. 10.1016/j.gene.2013.05.004 PubMed DOI PMC

Thalhammer A., Bencokova Z., Poole R., Loenarz C., Adam J., O'Flaherty L., et al. (2011). Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1a (HIF-1a). PLoSOne 6 (1), e16210. 10.1371/journal.pone.0016210 PubMed DOI PMC

WHO (2020). The top 10 causes of death. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.

Wilhelmi de Toledo F., Grundler F., Bergouignan A., Drinda S., Michalsen A. (2019). Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One 14 (1), e0209353. 10.1371/journal.pone.0209353 PubMed DOI PMC

Wu T., Hu E., Xu S., Chen M., Guo P., Dai Z., et al. (2021). clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov. (Camb) 2 (3), 100141. 10.1016/j.xinn.2021.100141 PubMed DOI PMC

Yoon H., Spinelli J. B., Zaganjor E., Wong S. J., German N. J., Randall E. C., et al. (2020). PHD3 loss promotes exercise capacity and fat oxidation in skeletal muscle. Cell Metab. 32 (2), 215–228. 10.1016/j.cmet.2020.06.017 PubMed DOI PMC